Resectable Liposarcoma: Clinical Trials

2 trials for Resectable Liposarcoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 not yet recruiting, 1 terminated. 1 Early Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Early Phase 11Terminated 1
Phase 31Not yet recruiting 1

Follow Resectable Liposarcoma: new trials by email Literature Review of Resectable Liposarcoma trials Research Report on Resectable Liposarcoma

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Pembrolizumab and Radiation Therapy With or Without Neoadjuvant Doxorubicin and Ifosfamide for the Treatment of High-Risk Resectable Undifferentiated Pleomorphic Sarcoma or Liposarcoma of the Extremity or Trunk Wall
Biospecimen Collection, Computed Tomography, Doxorubicin - Resectable Liposarcoma, Resectable Soft Tissue Sarcoma
Phase 3Not yet recruitingOhio State University Comprehensive Cancer Center2282026-12-012026-09-16
Heated Intra-peritoneal Chemotherapy With Doxorubicin and Cisplatin for Abdominal for Pelvic Tumors in Pediatric Patients
Cisplatin, Cytoreductive Surgery, Doxorubicin - Malignant Abdominal Neoplasm, Malignant Pelvic Neoplasm
Early Phase 1TerminatedMayo Clinic22019-11-082025-02-20

Narrower conditions

Colonic Neoplasms (1)  ·  Desmoplastic Small Round Cell Tumor (1)  ·  Fallopian Tube Neoplasms (1)  ·  Liposarcoma (1)  ·  Mesothelioma, Malignant (1)  ·  Ovarian Neoplasms (1)  ·  Pelvic Neoplasms (1)  ·  Rectal Neoplasms (1)  ·  Rhabdomyosarcoma (1)  ·  Sarcoma (1)  ·  Stomach Neoplasms (1)

Broader conditions

Adenoma (1)  ·  Adnexal Diseases (1)  ·  Colonic Diseases (1)  ·  Colorectal Neoplasms (1)  ·  Digestive System Diseases (1)  ·  Digestive System Neoplasms (1)  ·  Endocrine Gland Neoplasms (1)  ·  Endocrine System Diseases (1)  ·  Fallopian Tube Diseases (1)  ·  Female Urogenital Diseases (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)  ·  Gastrointestinal Diseases (1)  ·  Gastrointestinal Neoplasms (1)  ·  Genital Diseases (1)  ·  Genital Diseases, Female (1)

Interventions

Doxorubicin (2)  ·  Magnetic Resonance Spectroscopy (2)  ·  Specimen Handling (2)  ·  1,2-diaminocyclohexaneplatinum II citrate (1)  ·  Cisplatin (1)  ·  Cytoreduction Surgical Procedures (1)  ·  Hyperthermic Intraperitoneal Chemotherapy (1)  ·  Ifosfamide (1)  ·  Platinum (1)  ·  Radiotherapy, Intensity-Modulated (1)  ·  Surgical Procedures, Operative (1)  ·  X-Rays (1)  ·  pembrolizumab (1)  ·  sodium thiosulfate (1)

Sponsors

Mayo Clinic (1)  ·  Ohio State University Comprehensive Cancer Center (1)

Countries

United States (2)

Top investigators

David A Liebner (1)  ·  Patricio C. Gargollo, M.D. (1)